|
Data for this mutation
| Sample ID | MSH2 | MLH1 | MSH6 | MUTYH | APC |
|---|---|---|---|---|---|
| 19_12488_12488-001_12488- | - | - | - | - | - |
| 19_13872_13872-001_13872- | - | - | - | - | - |
| 19_13872_13872-002_13872- | - | - | - | - | - |
| 19_13872_13872-003_13872- | - | - | - | - | - |
| 19_1618_1618-001_1618-001 | - | - | - | - | - |
| 19_1618_1618-002_1618-002 | - | - | - | - | - |
| 19_2450124501.00124501.001 | - | - | - | - | - |
| 19_2499924999.00124999.001 | - | - | - | - | - |
| 19_3490_3490-001_3490-001 | - | - | - | - | - |
| 19_7081_7081-001_7081-001 | - | - | - | - | - |
| 19_7081_7081-002_7081-002 | - | - | - | - | - |
| 19_7081_7081-005_7081-005 | - | - | - | - | - |
| 19_7081_7081-006_7081-006 | - | - | - | - | - |
| 19_7081_7081-008_7081-008 | - | - | - | - | - |
| 19_7081_7081-009_7081-009 | - | - | - | - | - |
| 19_7081_7081-010_7081-010 | - | - | - | - | - |
| 19_7081_7081-014_7081-014 | - | - | - | - | - |
| 20_20-44554455-01--- | - | - | - | - | - |
| 2_02-ACT2284_15564_15564 | c.IVS7+51C>A (c.1276+51C>A) c.573C>T (p.Leu191Leu) | - | - | - | - |
| 4_CH43858321754717 | - | - | - | - | - |
| 5_2008289_20072812_AAC606 | c.IVS12-6T>C (c.2006-6T>C) | - | - | - | - |
| SO_-1328---G00343 | - | - | - | - | - |
| Analysis | Result | Date | Origin | PMID/dbSNP |
|---|---|---|---|---|
| Clinical phenotype | Multiple Lynch-related cancers (24501.001) | 13/05/14 | 19 (Rouen) | |
| Clinical phenotype | Sporadic Lynch-related cancer (endometrium) < 50 years old (24999.001) | 13/05/14 | 19 (Rouen) | |
| MMR function in tumor cells | MSI / MLH1+MSH2-MSH6- (24999.001) | 13/05/14 | 19 (Rouen) | |
| Clinical phenotype | Multiple Lynch-related cancers (24501.001) | 13/05/14 | 19 (Rouen) | |
| MMR function in tumor cells | MSI / MLH1+MSH2-MSH6- (endometrium) (24501.001) | 13/05/14 | 19 (Rouen) |
| Biological significance | Date | Comment |
|---|---|---|
| Causal | 21/02/14 | --- |
|
Consequences of the mutation at the protein level No data available |